查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1925469

活体小动物影像系统市场（按组件、影像方式、动物种类、应用和最终用户划分）－2026-2032年全球预测

Live Small Animal Imaging System Market by Component, Imaging Modality, Animal Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年，体内小动物影像系统市场价值为 3.1548 亿美元，预计到 2026 年将成长至 3.5383 亿美元，到 2032 年将达到 6.7326 亿美元，复合年增长率为 11.43%。

关键市场统计数据
基准年 2025 3.1548亿美元
预计年份：2026年 3.5383亿美元
预测年份 2032 6.7326亿美元
复合年增长率 (%) 11.43%

全面概述当代临床前影像平台及其在加速跨模态、跨模型和跨组织需求的转化研究中的作用

体内小动物影像系统是转化科学的关键平台技术，它透过对疾病生物学、治疗反应和安全性进行非侵入性、时间序列研究，连结了临床前发现和临床创新。这些系统整合了硬体、软体和服务生态系统，能够获得模式生物的解剖学、功能和分子资讯。检测器灵敏度、多重模式融合和计算分析技术的进步，使得临床前影像成为现代药物发现流程、疾病建模和机制研究的重要组成部分。因此，研究机构、生物技术公司和受託研究机构（CRO）越来越依赖整合成像平台来加快获得洞见的速度并提高体内实验的准确性。

混合成像、人工智慧驱动的分析以及服务主导采购等领域的进步如何融合，从根本上重塑临床前成像策略和营运模式？

近年来，技术进步、资料架构的演进以及对转换应用价值的重新重视，共同促成了变革性的改变。仪器设备不再局限于渐进式改进，而是采用了融合解剖学和分子读数的混合工作流程，使研究人员能够从单次实验中获得更丰富的生物学资讯。同时，检测器技术和重建演算法的改进提高了灵敏度和空间分辨率，结合先进的软体流程，实现了更精确的定量分析和可重复的终点结果。此外，人工智慧（AI）和机器学习在影像处理和表型分析领域的成熟，也使工作重心从人工处理转向自动化、可扩展的分析，从而提高了通量并减少了结果解读的差异。

探讨关税变化对临床前影像领域采购连续性、供应链韧性和整体拥有成本的影响

新关税和贸易政策调整的实施对临床前影像相关人员的供应链动态、采购计画和成本结构产生了复杂的影响。许多仪器依赖来自供应商分散的精密组件，而关税导致的成本增加可能会延长交货週期，因为製造商需要重新评估其筹资策略，优先考虑在地采购，并调整供应合约。对于研究机构和服务供应商，直接影响是前置作业时间支出可能需要重新分配，并且会更加关注总体拥有成本而非初始购买价格。这促使供应商和最终用户重新考虑维护和服务模式，以期维持运作并控制生命週期成本。

以细分市场主导，必须将各种技术优势、生物工作流程、应用优先顺序以及模组化服务和软体产品与客户需求相匹配。

了解细分市场趋势对于协调产品开发、商业策略和客户参与至关重要。影像方式涵盖微型电脑断层扫描（microCT）、微型磁振造影（microMRI）、微型正子断层扫描（microPET）、微型单光子发射电脑断层扫描（microSPECT）和光学成像，其中光学成像可细分为生物发光成像、萤光成像和光声成像。每种影像方式都各具优势：microCT 提供高解析度的解剖细节，microMRI 无需电离辐射即可实现软组织对比度，microPET 和 microSPECT 可用于分子示踪研究，而光学成像子模式则支援灵敏度的报告基因实验和快速表型筛检。因此，影像方式的选择与研究目标密切相关，许多调查计画受益于多重模式整合，以获得互补的终点指标。

影响采用趋势、监管协调和区域支持需求的地理因素（美洲、欧洲、中东和非洲、亚太地区）

区域趋势影响着美洲、欧洲、中东和非洲以及亚太地区的采用模式、监管要求和供应链结构。在美洲，充满活力的学术研究生态系统和强大的生物技术产业推动了先进成像解决方案的早期应用。采购往往倾向于选择拥有强大技术支援的综合整合平台，服务供应商和学术核心设施也经常与业界合作，检验新型成像生物标记。该地区对转化医学的重视促进了影像专家与药物发现和开发团队之间的合作，加速了候选药物从生物模型到临床试验的进程。

产品模组化、分析技术领先地位和卓越服务品质如何重塑临床前影像服务供应商的差异化策略和伙伴关係模式

临床前影像生态系统的竞争格局正在发生变化，各公司正透过平台整合、分析能力和服务模式来凸显自身差异。领先的技术供应商正加大对模组化系统的投入，以促进多重模式工作流程，并实现无需更换整台仪器即可进行功能升级。这种模组化设计有助于延长设备使用寿命，并实现平稳的技术迁移。软体和分析技术是另一个差异化维度。提供检验的流程、使用者友善介面和机器学习驱动的分析能力的供应商，正受到寻求更高可重复性和更快分析速度的客户的青睐。服务差异化同样重要，提供全面维护合约、远距离诊断和结构化培训计画的公司，能够提高仪器运转率和使用者熟练度，从而建立更牢固的长期合作关係。

供应商和研究机构可透过模组化系统、稳健的供应链、检验的分析和灵活的商业模式来提升价值，可采取切实可行的步骤。

产业领导者应优先考虑将硬体创新与强大的软体和服务生态系统结合的整合价值提案。投资支援多重模式工作流程的模组化架构，可以减少客户升级的阻力，并拓宽其可应用的场景范围。与硬体并行，企业应更加关注经过检验的分析管道和可解释的机器学习工具，这些工具可以减少变异性并加快结果获取速度。这种整合方法应辅以透明的整体拥有成本 (TCO) 资讯沟通，以便采购团队能够比较整个生命週期（而不仅仅是资本支出）中的各种方案。

本分析所依据的调查方法是严格的混合方法，结合专家访谈、技术文献、专利分析和供应链映射，检验趋势和策略要务。

本分析的调查方法结合了定性和定量方法，以确保获得切实可行的洞见。主要研究包括对测量工程师、成像科学家、采购主管和服务经理的访谈，以收集关于技术采纳、支援挑战和采购标准的第一手观点。次要研究包括对同行评审文献、专利申请、监管指导文件和会议报告的全面审查，以检验技术趋势和特定应用需求。此外，还进行了供应链映射和组件采购分析，以识别各区域潜在的瓶颈和提升韧性的机会。

整合技术、营运和政策因素，以决定临床前影像计画的策略方向和韧性。

临床前影像系统正处于策略转折点，技术创新、不断变化的营运预期和全球贸易趋势在此交汇融合。混合成像和分析技术的进步正在释放更丰富、更可重复的生物学洞见，而终端用户也日益寻求能够降低复杂性并加速研究成果的整合解决方案。同时，关税波动和供应链重组等外部压力，促使人们迫切需要关注系统的韧性、本地支援和透明的生命週期经济效益。这些因素共同推动相关人员采用更协作、以服务为导向的模式，强调长期伙伴关係而非交易型销售。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 体内小动物影像系统市场（依组件划分）

  • 装置
  • 服务
    • 维护
    • 支援服务
    • 训练
  • 软体

9. 依影像方式分類的体内小动物影像系统市场

  • 微型CT
  • 微型磁振造影
  • 微型PET
  • 微型SPECT
  • 光学成像
    • 生物发光成像
    • 萤光影像
    • 光声成像

第十章 依动物类型分類的活体小动物影像系统市场

  • 小鼠模型
  • 大鼠模型
  • 斑马鱼

第十一章 依应用分類的体内小动物影像系统市场

  • 循环系统
  • 药物发现
  • 神经病学
  • 肿瘤学

第十二章 依最终用户分類的体内小动物影像系统市场

  • 学术机构
  • 生技公司
  • CRO（受託研究机构）
  • 製药公司

第十三章 区域性小型动物体内影像系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 活体小动物影像系统市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国活体小动物影像系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国活体小动物影像系统市场

第十七章：中国活体小动物影像系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies Inc
  • Aspect Imaging Ltd
  • Bioscan Inc
  • Biospace Lab
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Gamma Medica Inc
  • GE Healthcare
  • Hitachi Ltd
  • Invicro LLC
  • Li-Cor Biosciences
  • Mediso Ltd
  • MILabs BV
  • MR Solutions Ltd
  • PerkinElmer Inc
  • Philips Healthcare
  • RayContrast Inc
  • Scintica Instrumentation Inc
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Sofie Biosciences Inc
  • Thermo Fisher Scientific Inc
  • Trifoil Imaging Inc
Product Code: MRR-7A380DA7C63F

The Live Small Animal Imaging System Market was valued at USD 315.48 million in 2025 and is projected to grow to USD 353.83 million in 2026, with a CAGR of 11.43%, reaching USD 673.26 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 315.48 million
Estimated Year [2026] USD 353.83 million
Forecast Year [2032] USD 673.26 million
CAGR (%) 11.43%

A comprehensive orientation to modern preclinical imaging platforms and their role in accelerating translational research across modalities, models, and organizational needs

The live small animal imaging system field is a critical enabler of translational science, bridging preclinical discovery and clinical innovation by enabling noninvasive longitudinal studies of disease biology, therapeutic response, and safety. These systems integrate hardware, software, and service ecosystems to capture anatomical, functional, and molecular information in model organisms. Advances in detector sensitivity, multi-modality fusion, and computational analytics have made preclinical imaging an indispensable component of modern drug discovery workflows, disease modeling, and mechanistic studies. As a result, research institutions, biotechnology innovators, and contract research organizations increasingly rely on integrated imaging platforms to reduce time-to-insight and improve the fidelity of in vivo experiments.

Within this context, the market landscape is studied across several imaging modalities including MicroCT, MicroMRI, MicroPET, MicroSPECT, and Optical Imaging, with Optical Imaging further characterized into Bioluminescence Imaging, Fluorescence Imaging, and Photoacoustic Imaging. Equally important is the diversity of animal models used to generate translationally relevant data, spanning Mouse Models, Rat Models, and Zebrafish, each offering distinct advantages in throughput, genetic tractability, and cost. Applications center on cardiovascular research, drug discovery programs, neurology investigations, and oncology studies, with end users ranging from academic institutes to biotechnology companies, contract research organizations, and pharmaceutical companies. Finally, the component landscape comprises Instruments, Services, and Software, where services include Maintenance, Support Services, and Training. Together, these interrelated segments shape procurement priorities, operational models, and the adoption curve for advanced imaging capabilities.

This introduction sets the stage for a deeper exploration of technological inflection points, regulatory and trade dynamics, and strategic imperatives that are redefining how organizations invest in and deploy preclinical imaging assets. By framing the field through modality, model organism, application, end user, and component lenses, stakeholders can better align investments with scientific objectives and institutional capacity.

How converging advances in hybrid imaging, AI-driven analytics, and service-driven procurement are fundamentally reshaping preclinical imaging strategies and operational models

The last several years have seen transformative shifts driven by converging technological advancements, evolving data architectures, and a renewed emphasis on translational relevance. Instrumentation has moved beyond incremental improvements to embrace hybrid workflows that fuse anatomical and molecular readouts, enabling researchers to derive richer biological context from single experimental sessions. Meanwhile, improvements in detector technology and reconstruction algorithms have increased sensitivity and spatial resolution, which, when paired with sophisticated software pipelines, allow for more precise quantification and reproducible endpoints. In parallel, the maturation of artificial intelligence and machine learning for image processing and phenotypic analysis is shifting labor from manual curation toward automated, scalable analytics, thereby increasing throughput and reducing interpretive variability.

Another major shift concerns operational models and service delivery. Organizations are prioritizing outcome-oriented partnerships with vendors that offer not only instruments but also long-term support, training, and managed services that lower the barrier to adoption. This trend is reinforced by the need for standardized protocols that enhance data comparability across multi-center studies and by a focus on interoperability between imaging modalities and laboratory information systems. Regulatory and ethical considerations are also influencing system design and study planning, with noninvasive imaging techniques increasingly preferred for their ability to reduce animal use through longitudinal measures and refine endpoint selection. Collectively, these technological, operational, and ethical shifts are reshaping value propositions across the preclinical imaging ecosystem and prompting stakeholders to reassess capital allocation, talent development, and collaborative strategies.

Navigating the implications of shifting tariff regimes on procurement continuity, supply chain resilience, and total cost of ownership for preclinical imaging portfolios

The introduction of new tariff measures and trade policy adjustments has created a complex overlay on supply chain dynamics, procurement planning, and cost structures for preclinical imaging stakeholders. Many instruments rely on precision components sourced from geographically dispersed suppliers, and tariff-induced cost inflation can lead to extended lead times as manufacturers reevaluate sourcing strategies, prioritize local content, or adjust supplier contracts. For research institutions and service providers, the immediate consequence is a potential reallocation of capital expenditures and a heightened focus on total cost of ownership rather than initial purchase price. Vendors and end users alike are therefore revisiting maintenance and service models to preserve uptime and manage lifecycle expenses.

Moreover, tariffs amplify the strategic importance of regional manufacturing footprints and distribution networks. Organizations with established local assembly or aftermarket support capabilities can reduce exposure to cross-border tariffs, whereas those dependent on fully imported systems may face higher landed costs and scheduling uncertainty. In response, some suppliers are accelerating localization of key subassemblies and strengthening regional partnerships to de-risk deliveries. From a software and training perspective, the impact is different but still material: licensing arrangements, cloud service dependencies, and remote training programs may incur indirect costs or administrative hurdles tied to regional compliance requirements. Ultimately, the cumulative effect of tariff measures prompts a reappraisal of procurement timing, inventory buffers, and supplier diversification strategies, compelling decision-makers to balance near-term operational continuity against longer-term investments in resilience.

Segment-driven imperatives for aligning modality strengths, organism workflows, application priorities, and modular service and software offerings to customer needs

Understanding segmentation dynamics is essential for aligning product development, commercial strategy, and customer engagement. The imaging modality landscape spans MicroCT, MicroMRI, MicroPET, MicroSPECT, and Optical Imaging, with Optical Imaging further delineated into Bioluminescence Imaging, Fluorescence Imaging, and Photoacoustic Imaging. Each modality delivers unique strengths: MicroCT provides high-resolution anatomical detail, MicroMRI offers soft-tissue contrast without ionizing radiation, MicroPET and MicroSPECT enable molecular tracer studies, and optical submodalities support sensitive reporter-based experiments and rapid phenotypic screening. Modality choice is therefore tightly coupled to study objectives, with many research programs benefitting from multi-modality integration to capture complementary endpoints.

Animal type choice is another determinant of experimental design, as Mouse Models, Rat Models, and Zebrafish each present trade-offs in genetic manipulability, physiological relevance, throughput potential, and handling complexity. These model organism decisions influence instrumentation configuration, imaging protocols, and throughput expectations. Application-focused segmentation highlights where imaging delivers the most value: cardiovascular research, drug discovery efforts, neurology investigations, and oncology studies frequently leverage imaging-derived biomarkers to track disease progression and therapeutic response. End users-academic institutes, biotechnology companies, contract research organizations, and pharmaceutical companies-exhibit distinct purchasing behaviors, budget cycles, and service expectations, which require tailored commercial and support models.

Finally, components define the revenue and engagement lifecycle: Instruments, Services, and Software. Within services, Maintenance, Support Services, and Training are critical to sustaining instrument uptime and ensuring data quality. Software investments span acquisition, image reconstruction, analytics, and laboratory integration, and the right combination of software and services often dictates long-term customer satisfaction. Insights from segmentation analysis therefore recommend harmonizing product roadmaps with modality strengths, model organism workflows, application needs, and end-user operational constraints, while delivering modular service and software options that scale with customer maturity.

Geographic considerations shaping adoption, regulatory alignment, and localized support requirements across the Americas, Europe Middle East Africa, and Asia Pacific

Regional dynamics influence adoption patterns, regulatory expectations, and supply chain configurations across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, vibrant academic research ecosystems and a robust biotech sector support early adoption of advanced imaging solutions. Procurement tends to favor comprehensive, integrated platforms backed by strong technical support, and service providers and academic cores often collaborate with industry to validate novel imaging biomarkers. This region's emphasis on translational pipelines encourages partnerships between imaging specialists and drug development teams to accelerate candidate progression from in vivo models to clinical trials.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, national funding models, and research priorities vary considerably. Established centers of excellence in oncology and neuroscience drive demand for high-end imaging modalities, while collaborative consortia emphasize standardization and cross-site reproducibility. In this region, service and training offerings that support protocol harmonization and cross-laboratory comparability are particularly valued. In contrast, Asia-Pacific demonstrates rapid expansion in both R&D capacity and local manufacturing capabilities. Investment in regional fabrication and aftermarket support is increasing, enabling faster delivery cycles and more cost-competitive service packages. Across these geographies, regional policy, talent availability, and logistical infrastructure shape procurement choices, with organizations often selecting partners who can demonstrate regulatory knowledge, localized support, and an ability to scale operations across complex multi-site studies.

How product modularity, analytics leadership, and service excellence are reshaping differentiation strategies and partnership models among preclinical imaging providers

Competitive dynamics in the preclinical imaging ecosystem are evolving as companies differentiate along platform integration, analytics capability, and service models. Leading technology providers are investing in modular systems that facilitate multi-modality workflows and enable customers to upgrade functionality without full instrument replacement. This modularity supports longer asset lifespans and smoother technology transitions. Another axis of differentiation is software and analytics: vendors that provide validated pipelines, user-friendly interfaces, and machine learning-enabled analytics gain traction with customers seeking reproducibility and reduced analysis timelines. Service differentiation is equally important; companies offering comprehensive maintenance contracts, remote diagnostics, and structured training programs enhance instrument uptime and user competency, which fosters stronger long-term relationships.

Strategic partnerships and collaborations are also reshaping the landscape. Alliances between instrument providers and contract research organizations or academic centers create co-development opportunities for novel tracers, imaging biomarkers, and standardized protocols. Additionally, some vendors are exploring subscription or pay-per-use models that reduce upfront barriers to adoption for emerging research groups, while larger institutions continue to evaluate total cost of ownership and lifecycle support. Overall, companies that balance product innovation with scalable service delivery and clear pathways for software integration are best positioned to meet the diverse needs of end users in academic, biotech, CRO, and pharmaceutical settings.

Practical steps for vendors and research organizations to enhance value through modular systems, resilient supply chains, validated analytics, and flexible commercial models

Industry leaders should prioritize an integrated value proposition that pairs hardware innovation with robust software and service ecosystems. Investing in modular architectures that support multi-modality workflows will reduce customer friction during upgrades and enable a broader addressable use case set. Alongside hardware, organizations must commit to validated analytics pipelines and explainable machine learning tools that reduce variability and accelerate time-to-result. This integrated approach should be complemented by transparent total cost of ownership communications that help procurement teams compare lifecycle options rather than just capital expenditure figures.

Operationally, companies and end users should strengthen supply chain resilience by diversifying suppliers, increasing local content where feasible, and maintaining strategic inventory buffers for critical subsystems. Service leaders should expand remote diagnostic capabilities and virtual training programs to support distributed user bases and minimize downtime. On the commercial front, adopting flexible commercial models-such as usage-based access, bundled service contracts, and tiered support-can lower adoption barriers and create recurring revenue streams. Finally, stakeholders must invest in standardized protocols and cross-site validation initiatives to enhance data interoperability and support multi-center studies, thereby increasing the translational value of imaging-derived biomarkers.

A rigorous mixed-methods approach combining expert interviews, technical literature, patent analysis, and supply chain mapping to validate trends and strategic imperatives

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure robust, actionable insights. Primary research included interviews with instrumentation engineers, imaging scientists, procurement leads, and service managers to capture firsthand perspectives on technology adoption, support challenges, and purchasing criteria. Secondary research involved a comprehensive review of peer-reviewed literature, patent filings, regulatory guidance documents, and conference proceedings to validate technological trends and application-specific requirements. Additionally, supply chain mapping and component sourcing analyses were conducted to identify potential bottlenecks and resilience opportunities across regions.

Data validation employed triangulation across multiple sources, reconciling operator interviews with technical specifications and vendor documentation. Scenario analysis was used to test the impact of trade policy shifts and supply disruptions on procurement timelines and service delivery. Finally, segmentation frameworks were applied to ensure insights were actionable for stakeholders aligned by modality, model organism, application, end user, and component, with special attention to the nuances within optical imaging submodalities and services. This mixed-methods approach provides a balanced view of technological trajectories, operational constraints, and strategic options for market participants.

Synthesis of technological, operational, and policy factors that will determine the strategic direction and resilience of preclinical imaging initiatives

Preclinical imaging systems sit at a strategic inflection point where technological innovation, evolving operational expectations, and global trade dynamics intersect. Advances in hybrid imaging and analytics are unlocking richer, more reproducible biological insights, while end users increasingly demand integrated solutions that reduce complexity and accelerate research outcomes. At the same time, external pressures such as tariff shifts and supply chain reconfiguration necessitate a sharper focus on resilience, localized support, and transparent lifecycle economics. These forces collectively encourage stakeholders to adopt more collaborative, service-oriented models that emphasize long-term partnerships over transactional sales.

Looking ahead, organizations that invest in modular platforms, validated analytics, strong service networks, and diversified supply chains will be better positioned to sustain research continuity and derive maximum value from imaging investments. Standardization and cross-site harmonization will further enhance the translational impact of imaging biomarkers, enabling more effective multi-center studies and collaborative drug development programs. In sum, the trajectory of preclinical imaging favors integrated, resilient, and data-driven approaches that align technological capability with operational practicality and strategic foresight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Live Small Animal Imaging System Market, by Component

  • 8.1. Instruments
  • 8.2. Services
    • 8.2.1. Maintenance
    • 8.2.2. Support Services
    • 8.2.3. Training
  • 8.3. Software

9. Live Small Animal Imaging System Market, by Imaging Modality

  • 9.1. MicroCT
  • 9.2. MicroMRI
  • 9.3. MicroPET
  • 9.4. MicroSPECT
  • 9.5. Optical Imaging
    • 9.5.1. Bioluminescence Imaging
    • 9.5.2. Fluorescence Imaging
    • 9.5.3. Photoacoustic Imaging

10. Live Small Animal Imaging System Market, by Animal Type

  • 10.1. Mouse Models
  • 10.2. Rat Models
  • 10.3. Zebrafish

11. Live Small Animal Imaging System Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Drug Discovery
  • 11.3. Neurology
  • 11.4. Oncology

12. Live Small Animal Imaging System Market, by End User

  • 12.1. Academic Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical Companies

13. Live Small Animal Imaging System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Live Small Animal Imaging System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Live Small Animal Imaging System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Live Small Animal Imaging System Market

17. China Live Small Animal Imaging System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies Inc
  • 18.6. Aspect Imaging Ltd
  • 18.7. Bioscan Inc
  • 18.8. Biospace Lab
  • 18.9. Bruker Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. Gamma Medica Inc
  • 18.13. GE Healthcare
  • 18.14. Hitachi Ltd
  • 18.15. Invicro LLC
  • 18.16. Li-Cor Biosciences
  • 18.17. Mediso Ltd
  • 18.18. MILabs BV
  • 18.19. MR Solutions Ltd
  • 18.20. PerkinElmer Inc
  • 18.21. Philips Healthcare
  • 18.22. RayContrast Inc
  • 18.23. Scintica Instrumentation Inc
  • 18.24. Shimadzu Corporation
  • 18.25. Siemens Healthineers AG
  • 18.26. Sofie Biosciences Inc
  • 18.27. Thermo Fisher Scientific Inc
  • 18.28. Trifoil Imaging Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROCT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROCT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROCT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROMRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROMRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROMRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROPET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROPET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROPET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROSPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROSPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MICROSPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY FLUORESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY FLUORESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY FLUORESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHOTOACOUSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MOUSE MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MOUSE MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY MOUSE MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY RAT MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY RAT MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY RAT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ZEBRAFISH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ZEBRAFISH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ZEBRAFISH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GCC LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 184. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 186. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. G7 LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 192. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 195. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA LIVE SMALL ANIMAL IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)